EyePoint Pharmaceuticals, Inc.
-
Ticker
EYPT
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Watertown, Massachusetts
EyePoint Pharmaceuticals, Inc. (www.eyepointpharma.com) is a pharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. The Company currently has two commercial products: DEXYCU®, the first approved intraocular product for the treatment of
…More postoperative inflammation, and YUTIQ®, a three-year treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The Company's pipeline leverages its proprietary bioerodible Durasert® technology for extended intraocular drug delivery including EYP-1901, a potential six-month anti-VEGF therapy initially targeting wet age-related macular degeneration. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts with offices in Basking Ridge, New Jersey.
EyePoint Pharmaceuticals, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 Environmental, Social and Governance (ESG) Performance Report
Report Locked. EyePoint Pharmaceuticals, Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived EyePoint Pharmaceuticals, Inc. Sustainability Report, EyePoint Pharmaceuticals, Inc. Corporate Social Responsibility Report, EyePoint Pharmaceuticals, Inc. CSR Report, EyePoint Pharmaceuticals, Inc. Corporate Responsibility, EyePoint Pharmaceuticals, Inc. CR Report, EyePoint Pharmaceuticals, Inc. Citizenship Report, EyePoint Pharmaceuticals, Inc. ESG Report, and EyePoint Pharmaceuticals, Inc. Environmental Report online.